CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands		At-the-Market Common shares	At-the-Market Additional Paid-In Capital	At-the-Market	Public offering Common shares	Public offering Additional Paid-In Capital	Public offering	Common shares	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2023	[1]								$ 66,446	$ (54,245)	$ 12,201
Balance at the beginning (in shares) at Dec. 31, 2023	[1]							17,418,886
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT)
Share-based payments									1,296		1,296
Issuance of restricted share awards (in shares)								434,527
Issuance of common shares, net of offering costs			$ 4,696	$ 4,696
Issuance of common shares, net of offering costs (in shares)		502,647
Net Income (Loss)										(4,171)	(4,171)
Balance at the end at Mar. 31, 2024									72,438	(58,416)	14,022
Balance at the end (in shares) at Mar. 31, 2024								18,356,060
Balance at the beginning at Dec. 31, 2024									82,958	(73,245)	9,713
Balance at the beginning (in shares) at Dec. 31, 2024								19,495,683
CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT)
Share-based payments									1,368		1,368
Issuance of restricted share awards (in shares)								844,087
Issuance of common shares, net of offering costs			$ 1,232	$ 1,232		$ 13,973	$ 13,973
Issuance of common shares, net of offering costs (in shares)		189,816		189,816	3,105,000
Net Income (Loss)										(5,332)	(5,332)
Balance at the end at Mar. 31, 2025									$ 99,531	$ (78,577)	$ 20,954
Balance at the end (in shares) at Mar. 31, 2025								23,634,586

[1] Represents an amount lower than $1 USD.